ArticleFrontiers in oncology2022

Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.

Annika Kurreck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.